GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SynCore Biotechnology Co Ltd (ROCO:4192) » Definitions » Purchase Of Investment

SynCore Biotechnology Co (ROCO:4192) Purchase Of Investment : NT$0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is SynCore Biotechnology Co Purchase Of Investment?

SynCore Biotechnology Co's purchase of investment for the three months ended in Mar. 2024 was NT$0.00 Mil. It means SynCore Biotechnology Co spent NT$0.00 Mil on purchasing investments. SynCore Biotechnology Co's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2024 was NT$0.00 Mil.

Compared with last quarter (NT$0.00 Mil in Dec. 2023 ), SynCore Biotechnology Co spent the same money on purchasing investments in Mar. 2024 (NT$0.00 Mil).


SynCore Biotechnology Co Purchase Of Investment Historical Data

The historical data trend for SynCore Biotechnology Co's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SynCore Biotechnology Co Purchase Of Investment Chart

SynCore Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

SynCore Biotechnology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

SynCore Biotechnology Co Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SynCore Biotechnology Co Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of SynCore Biotechnology Co's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


SynCore Biotechnology Co (ROCO:4192) Business Description

Traded in Other Exchanges
N/A
Address
No.84 Zhongshan Road, Zhongshan Village, Dongshan Township, Yilan, TWN, 269
SynCore Biotechnology Co Ltd is a biopharmaceutical company. Its pipeline products concentrate on the ophthalmology, oncology, and dermatology fields. The pipeline products of the company include SB01 and 02, SB03, SB04, and SB05. It is engaged in drug development and sale, food advisory, medicine inspection, biotechnology service and intellectual property. It operates in a single industry, the new drug development.

SynCore Biotechnology Co (ROCO:4192) Headlines

No Headlines